AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Precision Drilling Corporation

$89.03 +$15.35 (+20.83%)
NYSE · 15 Sep 2026 19:53 UTC
Previous Close
$86.5
Day Range
$87.26$89.84
Year Range
$53.42$103.8
Market Cap
1.14B
AVG Volume
106K
Trailing/Forward PE
-49.95/7.52
PEG ratio
-0.72
Dividend Yield
-
Next Earnings Date
2026-10-28
Primary Exchange
New York Stock ExchangeUS
Revenue (CAD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q21.92B
26 Q11.87B
25 Q41.84B
25 Q31.83B
25 Q21.85B
25 Q11.87B
24 Q41.9B
24 Q31.94B
24 Q21.79B
24 Q11.79B
Net Income (CAD) · TTM
-100M0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q2-32.76M
26 Q1-15.29M
25 Q41.84M
25 Q358.81M
25 Q2104.76M
25 Q1109.19M
24 Q4111.19M
24 Q3243.12M
24 Q2218.51M
24 Q1224.71M
Operating Income (CAD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q2142.41M
26 Q1161.27M
25 Q4184.12M
25 Q3251.65M
25 Q2201.37M
25 Q1209.43M
24 Q4211.91M
24 Q3236.5M
24 Q2199.61M
24 Q1226.31M
EBITDA (CAD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q2398.26M
26 Q1414.61M
25 Q4430.56M
25 Q3492.41M
25 Q2517M
25 Q1525.4M
24 Q4531.58M
24 Q3589.97M
24 Q2533.87M
24 Q1551.37M
Cash Flows (CAD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q2118.54M
26 Q1144.06M
25 Q4149.37M
25 Q3208.61M
25 Q2217.89M
25 Q1258.82M
24 Q4265.38M
24 Q3258.18M
24 Q2278.46M
24 Q1311.56M
EPS (CAD) · TTM
-50510152024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q2-2.44
26 Q1-1.28
25 Q4-0.43
25 Q33.85
25 Q26.64
25 Q17.01
24 Q47.34
24 Q316.09
24 Q215.23
24 Q115.42
Expenses (CAD) · TTM
0200M400M600MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q2420.3M
26 Q1395.03M
25 Q4377.85M
25 Q3361.63M
25 Q2348.63M
25 Q1338.19M
24 Q4349.12M
24 Q3367.57M
24 Q2365.37M
24 Q1366.34M
Shares Outstanding (CAD) · TTM
-50M050M100MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PDS Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
26 Q238.24M
26 Q139.88M
25 Q463.61M
25 Q362.69M
25 Q273.76M
25 Q181.72M
24 Q456.6M
24 Q355.52M
24 Q229.67M
24 Q116.82M
Dividends (CAD)
00.511.5Aug 13Oct 13Feb 14May 14Aug 14Nov 14Feb 15May 15Aug 15Nov 15
PDS Dividends (CAD) by quarter
PeriodDividends (CAD)
Nov 151.08
Aug 151.06
May 151.16
Feb 151.12
Nov 141.24
Aug 141.12
May 141.09
Feb 141.08
Oct 131.14
Aug 130.96
Employee Count
02K4K6K8K2002200320042005200620072009
PDS Employee Count by quarter
PeriodEmployee Count
20097.2K
20074.6K
20065.5K
20056.5K
20041.3K
200322
200219
PE Ratio
02505007501000med 7.84Aug 24Nov 24Feb 25Jun 25Sep 25Jan 26Apr 26
PDS PE Ratio by quarter
PeriodPE Ratio
Apr 26921.21
Apr 26810.77
Apr 26904.29
Apr 26931.83
Mar 26992.19
Mar 26958.83
Mar 26898.48
Mar 2627.71
Feb 2627.02
Feb 2627.5
Feb 2627.1
Feb 2627.15
Jan 2624.74
Jan 2623.86
Jan 2623.46
Jan 2622.59
Jan 2623.05
Dec 2521.59
Dec 2521.93
Dec 2521.53
Dec 2521.49
Nov 2519.7
Nov 2518.31
Nov 2518.7
Nov 2518.56
Oct 2519.11
Oct 2518.98
Oct 259.72
Oct 259.58
Oct 2510.36
Sep 2510.54
Sep 2510.04
Sep 2510.19
Sep 2510.04
Aug 2510.16
Aug 2510.11
Aug 259.55
Aug 259.66
Aug 259.56
Jul 258.92
Jul 258.79
Jul 258.69
Jul 258.6
Jun 258.08
Jun 258.7
Jun 258.7
Jun 258.2
May 257.41
May 257.28
May 257.61
May 257.4
May 257.5
Apr 257.49
Apr 257.56
Apr 257.41
Apr 257.07
Mar 258.16
Mar 258.12
Mar 258.07
Mar 253.88
Feb 254.19
Feb 254.46
Feb 254.5
Feb 254.66
Jan 254.92
Jan 255.28
Jan 255.51
Jan 255.43
Jan 255.35
Dec 244.84
Dec 244.73
Dec 244.99
Dec 244.85
Nov 245.14
Nov 245.39
Nov 245.1
Nov 245.17
Nov 244.81
Oct 245.38
Oct 245.49
Oct 245.73
Oct 245.8
Sep 245.51
Sep 245.94
Sep 245.68
Sep 245.82
Aug 246.42
Aug 246.44
Aug 246.29
Aug 246.19
Aug 246.36
Jul 246.48
Jul 246.3
Jul 246.3
Jul 246.03
Jun 246.17
Jun 245.84
Jun 245.77
Jun 245.88
May 246.51
Free Cash Flow Yield
0%10%20%30%40%med 19.62%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PDS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 267.64%
Sep 267.37%
Sep 267.37%
Aug 267.32%
Aug 267.27%
Aug 267.81%
Aug 268.69%
Jul 268.42%
Jul 269.34%
Jul 269.5%
Jul 269.8%
Jul 2610.38%
Jun 2610.11%
Jun 269.41%
Jun 268.31%
Jun 268.59%
May 269.04%
May 268.31%
May 268.53%
May 269.28%
May 268.66%
Apr 268.8%
Apr 2610%
Apr 268.97%
Apr 268.7%
Mar 268.17%
Mar 268.46%
Mar 269.03%
Mar 2612.8%
Feb 2613.13%
Feb 2612.9%
Feb 2613.09%
Feb 2613.06%
Jan 2614.34%
Jan 2614.86%
Jan 2615.12%
Jan 2615.7%
Jan 2615.39%
Dec 2516.43%
Dec 2516.17%
Dec 2516.47%
Dec 2516.51%
Nov 2518%
Nov 2519.37%
Nov 2518.97%
Nov 2519.11%
Oct 2518.56%
Oct 2518.68%
Oct 2521.4%
Oct 2521.72%
Oct 2520.08%
Sep 2519.74%
Sep 2520.71%
Sep 2520.41%
Sep 2520.72%
Aug 2520.47%
Aug 2520.56%
Aug 2521.79%
Aug 2521.53%
Aug 2521.77%
Jul 2526.57%
Jul 2526.96%
Jul 2527.29%
Jul 2527.56%
Jun 2529.32%
Jun 2527.26%
Jun 2527.24%
Jun 2528.92%
May 2531.98%
May 2532.77%
May 2531.37%
May 2532.27%
May 2531.83%
Apr 2531.88%
Apr 2531.57%
Apr 2532.2%
Apr 2533.75%
Mar 2529.24%
Mar 2529.41%
Mar 2529.57%
Mar 2527.37%
Feb 2525.37%
Feb 2523.79%
Feb 2523.57%
Feb 2522.79%
Jan 2521.57%
Jan 2520.11%
Jan 2519.29%
Jan 2519.56%
Jan 2519.85%
Dec 2421.96%
Dec 2422.46%
Dec 2421.26%
Dec 2421.88%
Nov 2420.64%
Nov 2419.69%
Nov 2420.81%
Nov 2420.55%
Nov 2422.1%
Oct 2423.68%
Price to Sales
0.40.60.81med 0.64Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PDS Price to Sales by quarter
PeriodPrice to Sales
Sep 260.81
Sep 260.84
Sep 260.84
Aug 260.84
Aug 260.85
Aug 260.79
Aug 260.71
Jul 260.73
Jul 260.82
Jul 260.81
Jul 260.78
Jul 260.74
Jun 260.76
Jun 260.82
Jun 260.93
Jun 260.89
May 260.85
May 260.92
May 260.9
May 260.83
May 260.89
Apr 260.92
Apr 260.81
Apr 260.9
Apr 260.93
Mar 260.99
Mar 260.96
Mar 260.9
Mar 260.89
Feb 260.87
Feb 260.88
Feb 260.87
Feb 260.87
Jan 260.79
Jan 260.77
Jan 260.75
Jan 260.72
Jan 260.74
Dec 250.69
Dec 250.7
Dec 250.69
Dec 250.69
Nov 250.63
Nov 250.59
Nov 250.6
Nov 250.6
Oct 250.61
Oct 250.61
Oct 250.55
Oct 250.54
Oct 250.59
Sep 250.6
Sep 250.57
Sep 250.58
Sep 250.57
Aug 250.58
Aug 250.57
Aug 250.54
Aug 250.55
Aug 250.54
Jul 250.52
Jul 250.51
Jul 250.51
Jul 250.5
Jun 250.47
Jun 250.51
Jun 250.51
Jun 250.48
May 250.43
May 250.43
May 250.44
May 250.43
May 250.44
Apr 250.44
Apr 250.44
Apr 250.43
Apr 250.41
Mar 250.48
Mar 250.47
Mar 250.47
Mar 250.49
Feb 250.52
Feb 250.56
Feb 250.56
Feb 250.58
Jan 250.62
Jan 250.66
Jan 250.69
Jan 250.68
Jan 250.67
Dec 240.61
Dec 240.59
Dec 240.63
Dec 240.61
Nov 240.64
Nov 240.68
Nov 240.64
Nov 240.65
Nov 240.6
Oct 240.66
EV/EBITDA
3456med 3.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PDS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 265.48
Sep 265.62
Sep 265.62
Aug 265.65
Aug 265.68
Aug 265.39
Aug 265.01
Jul 265.12
Jul 265.43
Jul 265.37
Jul 265.26
Jul 265.06
Jun 265.15
Jun 265.41
Jun 265.9
Jun 265.76
May 265.56
May 265.89
May 265.79
May 265.46
May 265.73
Apr 265.47
Apr 265
Apr 265.4
Apr 265.52
Mar 265.77
Mar 265.63
Mar 265.37
Mar 264.76
Feb 264.68
Feb 264.74
Feb 264.69
Feb 264.7
Jan 264.41
Jan 264.3
Jan 264.26
Jan 264.15
Jan 264.21
Dec 254.03
Dec 254.07
Dec 254.03
Dec 254.02
Nov 253.81
Nov 253.64
Nov 253.69
Nov 253.67
Oct 253.74
Oct 253.72
Oct 253.33
Oct 253.3
Oct 253.46
Sep 253.49
Sep 253.39
Sep 253.42
Sep 253.39
Aug 253.42
Aug 253.41
Aug 253.29
Aug 253.32
Aug 253.3
Jul 253.46
Jul 253.43
Jul 253.41
Jul 253.39
Jun 253.28
Jun 253.41
Jun 253.41
Jun 253.3
May 253.14
May 253.05
May 253.12
May 253.08
May 253.1
Apr 253.1
Apr 253.11
Apr 253.08
Apr 253.01
Mar 253.24
Mar 253.23
Mar 253.22
Mar 253.02
Feb 253.14
Feb 253.26
Feb 253.28
Feb 253.34
Jan 253.45
Jan 253.59
Jan 253.69
Jan 253.66
Jan 253.62
Dec 243.41
Dec 243.37
Dec 243.48
Dec 243.42
Nov 243.54
Nov 243.64
Nov 243.52
Nov 243.55
Nov 243.4
Oct 243.84
Price/Operating Cashflow
12345med 2.54Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PDS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 263.78
Sep 263.92
Sep 263.91
Aug 263.94
Aug 263.97
Aug 263.69
Aug 263.32
Jul 263.43
Jul 263.74
Jul 263.68
Jul 263.56
Jul 263.36
Jun 263.45
Jun 263.71
Jun 264.2
Jun 264.06
May 263.86
May 264.2
May 264.09
May 263.76
May 264.03
Apr 264.11
Apr 263.62
Apr 264.04
Apr 264.16
Mar 264.43
Mar 264.28
Mar 264.01
Mar 263.63
Feb 263.53
Feb 263.6
Feb 263.54
Feb 263.55
Jan 263.24
Jan 263.12
Jan 263.07
Jan 262.96
Jan 263.01
Dec 252.82
Dec 252.87
Dec 252.82
Dec 252.81
Nov 252.58
Nov 252.4
Nov 252.45
Nov 252.43
Oct 252.5
Oct 252.48
Oct 252.25
Oct 252.21
Oct 252.39
Sep 252.43
Sep 252.32
Sep 252.35
Sep 252.32
Aug 252.35
Aug 252.34
Aug 252.21
Aug 252.23
Aug 252.21
Jul 252.03
Jul 252
Jul 251.98
Jul 251.96
Jun 251.84
Jun 251.98
Jun 251.98
Jun 251.86
May 251.69
May 251.68
May 251.75
May 251.71
May 251.73
Apr 251.73
Apr 251.74
Apr 251.71
Apr 251.63
Mar 251.88
Mar 251.87
Mar 251.86
Mar 251.93
Feb 252.08
Feb 252.22
Feb 252.24
Feb 252.31
Jan 252.45
Jan 252.62
Jan 252.73
Jan 252.7
Jan 252.66
Dec 242.4
Dec 242.35
Dec 242.48
Dec 242.41
Nov 242.55
Nov 242.68
Nov 242.53
Nov 242.57
Nov 242.39
Oct 242.36
Price to Book
0.40.60.811.2med 0.74Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PDS Price to Book by quarter
PeriodPrice to Book
Sep 260.97
Sep 261
Sep 261
Aug 261.01
Aug 261.02
Aug 260.95
Aug 260.85
Jul 260.88
Jul 260.95
Jul 260.93
Jul 260.9
Jul 260.85
Jun 260.88
Jun 260.94
Jun 261.07
Jun 261.03
May 260.98
May 261.06
May 261.04
May 260.95
May 261.02
Apr 261.07
Apr 260.94
Apr 261.05
Apr 261.08
Mar 261.15
Mar 261.11
Mar 261.04
Mar 260.98
Feb 260.95
Feb 260.97
Feb 260.96
Feb 260.96
Jan 260.87
Jan 260.84
Jan 260.83
Jan 260.8
Jan 260.81
Dec 250.76
Dec 250.77
Dec 250.76
Dec 250.76
Nov 250.7
Nov 250.65
Nov 250.66
Nov 250.65
Oct 250.67
Oct 250.67
Oct 250.61
Oct 250.6
Oct 250.65
Sep 250.66
Sep 250.63
Sep 250.64
Sep 250.63
Aug 250.64
Aug 250.64
Aug 250.6
Aug 250.61
Aug 250.6
Jul 250.57
Jul 250.56
Jul 250.56
Jul 250.55
Jun 250.52
Jun 250.56
Jun 250.56
Jun 250.53
May 250.48
May 250.48
May 250.5
May 250.49
May 250.5
Apr 250.49
Apr 250.5
Apr 250.49
Apr 250.47
Mar 250.54
Mar 250.54
Mar 250.53
Mar 250.57
Feb 250.61
Feb 250.65
Feb 250.66
Feb 250.68
Jan 250.72
Jan 250.77
Jan 250.81
Jan 250.79
Jan 250.78
Dec 240.71
Dec 240.69
Dec 240.73
Dec 240.71
Nov 240.75
Nov 240.79
Nov 240.75
Nov 240.76
Nov 240.7
Oct 240.72
Precision Drilling Corporation
PDS
Stockpicker

Video analysis: PDS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PDS

Precision Drilling: U.S. Margin Recovery Could Drive A Rerating

seekingalpha.com · 11 Sep 2026

Precision Drilling: U.S. Margin Recovery Could Drive A Rerating

Precision Drilling (PDS) has strengthened its balance sheet, reduced debt, and operates a premium rig fleet with increasing activity, especially in Canada. Q2 revenue grew 11% to C$452.8M, but adjusted EBITDA fell 10% due to reactivation and upgrade costs, highlighting the need for margin recovery, particularly in the U.S. Contracted rigs in both Canada and the U.S. provide greater revenue visibility, but future margin improvement, especially from U.S. rigs, remains a key catalyst and risk.

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

globenewswire.com · 8 Sep 2026

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Dr. Soon-Shiong will Join PDS Biotech's Board of Directors PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today announced it has raised up to $22.55 million in equity funding in a Private Investment in Public Equity (“PIPE”) transaction.

Financial Survey: Precision Drilling (NYSE:PDS) and Technip Energies (OTCMKTS:THNPY)

defenseworld.net · 4 Sep 2026

Financial Survey: Precision Drilling (NYSE:PDS) and Technip Energies (OTCMKTS:THNPY)

Precision Drilling (NYSE: PDS - Get Free Report) and Technip Energies (OTCMKTS:THNPY - Get Free Report) are both energy companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Institutional and Insider Ownership 48.9% of Precision Drilling

Financial Contrast: STEP Energy Services (OTCMKTS:SNVVF) versus Precision Drilling (NYSE:PDS)

defenseworld.net · 28 Aug 2026

Financial Contrast: STEP Energy Services (OTCMKTS:SNVVF) versus Precision Drilling (NYSE:PDS)

STEP Energy Services (OTCMKTS:SNVVF - Get Free Report) and Precision Drilling (NYSE: PDS - Get Free Report) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings. Earnings and Valuation This table compares STEP

PDS Biotech Reports Second Quarter 2026 Financial Results

globenewswire.com · 13 Aug 2026

PDS Biotech Reports Second Quarter 2026 Financial Results

PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today provided a business and clinical programs update and reported financial results for the quarter ended June 30, 2026.

PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program

benzinga.com · 11 Aug 2026

PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program

PDS Biotechnology Corporation (NASDAQ:PDSB) shares have fallen by about 67% on Tuesday as the company announced a strategic refocus on its PDS0301 program for metastatic colorectal cancer.

Will Lower PDS Margin Affect Aveanna Healthcare's Q2 Earnings?

zacks.com · 10 Aug 2026

Will Lower PDS Margin Affect Aveanna Healthcare's Q2 Earnings?

AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.

Dimensional Fund Advisors LP Raises Stake in Precision Drilling Corporation $PDS

defenseworld.net · 6 Aug 2026

Dimensional Fund Advisors LP Raises Stake in Precision Drilling Corporation $PDS

Dimensional Fund Advisors LP grew its holdings in Precision Drilling Corporation (NYSE: PDS) (TSE: PD) by 37.0% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 288,013 shares of the oil and gas company's stock after buying an additional 77,775 shares during the period. Dimensional Fund Advisors

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.